AVTX vs QCOM · P/E 0.0, rev $441.0K vs P/E 16, rev $44.28B
Avalo Therapeutics Inc (AVTX) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the AVTX and QCOM stock pages for the full models.
Not investment advice.